Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Carlos E, Guzmán"'
Autor:
José Luis Assad-Morell, Edgar Francisco Carrizales-Sepúlveda, Carlos E Guzmán, Carla Gabriela Guzmán-Moreno
Publikováno v:
European Heart Journal: Case Reports
Background Goji berries (GB), usually marketed as a ‘superfruit’, are a widely used herbal supplement. As with other herbal remedies, the use of GB might be associated with herb–drug interactions, increasing plasma levels of other drugs and cau
Publikováno v:
Revista espanola de cardiologia. 64(7)
Autor:
Carlos Felipe, Barrera-Ramírez, Luis R, Pineda-Pompa, Mario, Melo, Ricardo, Valdez Castro, Héctor, Medina-Gómez, Gustavo, Godina-Alonso, Carlos E, Guzmán
Publikováno v:
Archivos de cardiologia de Mexico. 75
Systemic lupus erythematosus is a chronic inflammatory autoimmune disorder that can affect any organ or system. Although pericarditis is the most frequent cardiac manifestation of this entity, usually is not a life threatening situation. Pericardial
Autor:
Luis Ramón, Pineda Pompa, Carlos Felipe, Barrera-Ramírez, Jesús, Martínez-Valdez, Pedro Domínguez, Rodríguez, Carlos E, Guzmán
Publikováno v:
Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology. 23(4)
Acute noncardiogenic pulmonary edema and catecholamine-induced cardiomyopathy as the first presentations of pheochromocytoma are uncommon events, but usually rapidly fatal. A 36-year-old man presented acute pulmonary edema in a setting of hypertensiv
Publikováno v:
Archives of medical research. 30(3)
Patients with syncope show different responses to head-up tilt (HUT) test, which may be due to different pathophysiological mechanisms.HUT (70 degrees) was performed in 24 patients who experienced recurrent syncope. Nine patients had a cardioinhibito
Publikováno v:
Revista Española de Cardiología (English Edition). 57:1251-1252
Publikováno v:
Revista Española de Cardiología. 57:1251-1252
Publikováno v:
Revista Española de Cardiología (English Edition). 64:629
Hemos leido con interes el editorial de los Dres. Freedman e Iafrati recientemente publicado en REVISTA ESPANOLA DE CARDIOLOGIA. En dicho editorial, se menciona que el prasugrel es un inhibidor del receptor P2Y12 que no se metaboliza en el higado y n
Publikováno v:
Revista Española de Cardiología. 64:629